Case Report

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup

Figure 10

Three months later, the BCVA was 20/80, and although the condition of the fundus eye had improved (a), there was a great PED at FA and cirrus HD-OCT ((c) and (d)) with persistence of the polypoid lesion in the ICGA and cirrus HD-OCT ((f) and (d)), which led to a new PDT session on the polyp (spot size 1500 microns).
897097.fig.0010a
(a)
897097.fig.0010b
(b)
897097.fig.0010c
(c)
897097.fig.0010d
(d)
897097.fig.0010e
(e)
897097.fig.0010f
(f)